- We will send in 10–14 business days.
/images/books/14452371/9783031508431.jpg)
- Author: Sudip Mukherjee
- Publisher: Springer
- ISBN-10: 3031508432
- ISBN-13: 9783031508431
- Format: 24 x 16.8 x 1 cm, kieti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Recent Advancements of Immunomodulatory Biomaterials in Cell Therapy and Tissue Engineering (e-book) (used book) | bookbook.eu
Reviews
Description
This book presents the recent developments in immunomodulatory biomaterials for cell-based therapies in various diseases, including diabetes, cancer, cardiovascular disease, and bone regeneration. The authors first cover the fundamentals of conventional immunology and immunomodulation, before focusing on the history, advantages, and challenges of cell therapies. Biological cell therapy has gained immense attention for various diseases due to unique advantages it has over chemical drugs regarding cost, ease of production, toxicity, and therapeutic efficacy. However, these cell-based therapies need an inert delivery system that can locally deliver cells and minimally elicit foreign body response. The book discusses the foreign body response to the immunomodulatory biomaterials as well as the current and future strategies for potential mitigation of considerable immune responses toward immunomodulatory biomaterials and devices.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 23d.03:14:22
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Sudip Mukherjee
- Publisher: Springer
- ISBN-10: 3031508432
- ISBN-13: 9783031508431
- Format: 24 x 16.8 x 1 cm, kieti viršeliai
- Language: English English
This book presents the recent developments in immunomodulatory biomaterials for cell-based therapies in various diseases, including diabetes, cancer, cardiovascular disease, and bone regeneration. The authors first cover the fundamentals of conventional immunology and immunomodulation, before focusing on the history, advantages, and challenges of cell therapies. Biological cell therapy has gained immense attention for various diseases due to unique advantages it has over chemical drugs regarding cost, ease of production, toxicity, and therapeutic efficacy. However, these cell-based therapies need an inert delivery system that can locally deliver cells and minimally elicit foreign body response. The book discusses the foreign body response to the immunomodulatory biomaterials as well as the current and future strategies for potential mitigation of considerable immune responses toward immunomodulatory biomaterials and devices.
Reviews